Evidence map›Paper›PMID 40463261›Full record

ArticlebioRxiv : the preprint server for biology2025

Frequency and Characterization of Rare Histologic Subtypes in Canine Invasive Urothelial Carcinoma.

Megan P Corbett, Mohamed Elbadawy, Andrew P Woodward, John C Cheville, Hannah Wickham, Hannah Nicholson, Michael Catucci, Bryan J Melvin, Basant Ahmed, Christopher Zdyrski and 6 more

Abstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Megan P CorbettPrecision One Health Initiative, Department of Pathology, University of Georgia College of Veterinary Medicine, 30602 Athens, GA USA.ORCID 0009-0009-3277-5525
Mohamed ElbadawyPrecision One Health Initiative, Department of Pathology, University of Georgia College of Veterinary Medicine, 30602 Athens, GA USA.ORCID 0000-0001-9368-1535
Andrew P WoodwardPrecision One Health Initiative, Department of Pathology, University of Georgia College of Veterinary Medicine, 30602 Athens, GA USA.ORCID 0000-0001-5464-9567
John C ChevilleDepartment of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN 55902, USA.ORCID 0000-0002-8202-6268
Hannah WickhamSMART Pharmacology, Department of Biomedical Sciences, Iowa State University, Ames, IA, USA.ORCID 0000-0003-1395-2863
Hannah NicholsonPrecision One Health Initiative, Department of Pathology, University of Georgia College of Veterinary Medicine, 30602 Athens, GA USA.ORCID 0009-0008-3223-2443
Michael CatucciPrecision One Health Initiative, Department of Pathology, University of Georgia College of Veterinary Medicine, 30602 Athens, GA USA.ORCID 0009-0002-4042-9779
Bryan J MelvinPrecision One Health Initiative, Department of Pathology, University of Georgia College of Veterinary Medicine, 30602 Athens, GA USA.ORCID 0009-0007-8035-8756
Basant AhmedSMART Pharmacology, Department of Biomedical Sciences, Iowa State University, Ames, IA, USA.ORCID 0000-0003-1517-8015
Christopher ZdyrskiPrecision One Health Initiative, Department of Pathology, University of Georgia College of Veterinary Medicine, 30602 Athens, GA USA.ORCID 0000-0002-7556-5298
Lilian J OliveiraDepartment of Pathology, College of Veterinary Medicine, University of Georgia, Athens, GA 30602, USA.ORCID 0000-0003-1402-8373
Elizabeth W HowerthDepartment of Pathology, College of Veterinary Medicine, University of Georgia, Athens, GA 30602, USA.ORCID 0000-0001-6358-1381
Aleksandra PawlakPrecision One Health Initiative, Department of Pathology, University of Georgia College of Veterinary Medicine, 30602 Athens, GA USA.ORCID 0000-0002-7449-1661
Olufemi FasinaDepartment of Veterinary Pathology, Iowa State University, Ames, IA, USA.ORCID 0000-0003-3893-5234
Jonathan P MochelPrecision One Health Initiative, Department of Pathology, University of Georgia College of Veterinary Medicine, 30602 Athens, GA USA.ORCID 0000-0002-0997-3111
Karin AllenspachPrecision One Health Initiative, Department of Pathology, University of Georgia College of Veterinary Medicine, 30602 Athens, GA USA.ORCID 0000-0002-2168-5809

Funding

Using Canine Organoids to Advance Therapeutic Drug Development in Bladder CancerR21CA267372 · NCI · UNIVERSITY OF GEORGIA · PI ALLENSPACH, KARIN, MOCHEL, JONATHAN PAUL · 2022 to 2023
$544k
NCI NIH HHS R21 CA267372
6 · The paper itself

Abstract

The histologic and molecular heterogeneity of human muscle-invasive bladder cancer (MIBC) is a major contributor to poor treatment outcomes. While most cases of MIBC are diagnosed as conventional urothelial carcinoma (UC), there is growing recognition of histologic subtypes and divergent differentiation within conventional UC. This is clinically significant, as some require modification of therapy and some are associated with more aggressive behavior. Spontaneously occurring UC in dogs has been shown to exhibit histologic and molecular features that closely resemble those of human MIBC. In this study, we evaluated 31 canine UC tumor samples for histologic subtypes and divergent differentiation. Slides were reviewed by a human uropathologist and three board-certified veterinary pathologists and assessed for expression of uroplakin III and E-cadherin. All tumors were classified as high-grade UC. Fifteen cases were identified as conventional UC. Among the remainder, eight displayed glandular differentiation, four were classified as sarcomatoid UC, two showed squamous differentiation, and one case each was classified as large nested and tubular and microcystic subtypes. In summary, this study found a higher frequency of certain histologic subtypes and divergent differentiation in canine UC-particularly sarcomatoid UC and UC with glandular differentiation-compared to previous reports in both canine UC and human MIBC. Conclusion: The relatively high prevalence of the sarcomatoid UC subtype in dogs observed in this study suggests that canine UC may serve as a valuable translational model for evaluating novel therapeutic agents, particularly for this rare and aggressive variant in humans.

Indexed as

caninedivergent differentiationsarcomatoidsubtypetransitional celltranslationalurothelial carcinoma

Identifiers

PMID40463261
PMCPMC12132475

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.